Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy

Table 6

Analysis of influencing factors of CA153 change magnitude during chemotherapy.

Factor	Change magnitude of CA153	Univariate analysis		Multivariate analysis
		Age
≤57		4.632	0.034	0.888	0.349
>57
Menstruation
Yes		2.251	0.137
No
Comorbidities
No		4.851	0.030	3.144	0.080
Yes
BMI
≤24		0.055	0.814
>24
Tumor size
≤2 cm		0.342	0.560
>2 cm
Nodal status
0		7.560	0.026	4.479	0.014
1-3
≥4
HR status
Positive		0.307	0.581
Negative
ALT change magnitude
≤0.13		0.849	0.359
>0.13
AST change magnitude
≤0.05		0.406	0.526
>0.05
rGT change magnitude
≤0.35		2.402	0.125
>0.35
Triglyceride change magnitude
≤0.18		0.416	0.520
>0.18
Cholesterol change magnitude
≤0.077		0.187	0.667
>0.077
Fasting blood glucose change magnitude
≤0.05		1.337	0.251
>0.05
Initial WBC
≤6.27		10.571	0.002	2.910	0.092
>6.27
Initial NEUT
≤3.50		7.748	0.007	0.657	0.420
>3.50
Initial MONO
≤0.29		0.298	0.586
>0.29
Initial LY
≤1.95		0.528	0.469
>1.95
Initial PLT/LY
≤117.54		0.353	0.554
>117.54
Initial NEUT/LY
≤1.74		1.457	0.231
>1.74
Initial LY/MONO
≤6.61		0.230	0.633
>6.61
Initial SII
≤410.69		2.989	0.087
>410.69